Additional manufacturer narrative: the device was not returned for evaluation as it was discarded by the customer.Two pictures of the explanted valve were sent and reviewed.As per image evaluation, customer report of gradient increase and leaflet thickening was unable to be confirmed through image evaluation.Customer report of thrombus was confirmed through evaluation of the images provided.Pictures showed the outflow aspect of an explanted valve.What appeared to be vegetation was visible on the leaflets.Sewing ring was observed to be cut off around the valve.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
Updated d4 (device expiration date) and h4 (device manufacturer date).Updated section b4 (date of this report), g3 (date received by manufacturer), h6 (health effect - clinical code), h6 (type of investigation), h6 (investigation findings) and h6 (investigations conclusions).Corrected h6 (type of investigation), included "device discarded" instead of "device not accessible for testing" h10: additional manufacturer narrative: the device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.There were no issues identified that would have impacted this event.Valve thrombosis is the formation of significant blood clots forming on the valve/ring.These clots could significantly impact the functionality of the valve resulting in heart failure or thromboembolism.In this case, the most likely cause is patient factors.
|